-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BQ+fPoh85gqhDyXzb2XmfmT8rbwBQ0cTbOJE5Zxt7NyqvqP9/CLsAMXMct3G1e6u 0X51MhRDCyPmtDq2qbIWsA== 0001209191-07-006149.txt : 20070130 0001209191-07-006149.hdr.sgml : 20070130 20070130194950 ACCESSION NUMBER: 0001209191-07-006149 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070126 FILED AS OF DATE: 20070130 DATE AS OF CHANGE: 20070130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Solexa, Inc. CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 25861 INDUSTRIAL BLVD CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: LYNX THERAPEUTICS INC DATE OF NAME CHANGE: 19931008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAUSER HERMANN CENTRAL INDEX KEY: 0001207296 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22570 FILM NUMBER: 07565987 MAIL ADDRESS: STREET 1: GLOBESPANVIRATA INC STREET 2: 100 SCHULZ DR CITY: RED BANK STATE: NJ ZIP: 07701 4 1 bsf26824_bsf3hh.xml MAIN DOCUMENT DESCRIPTION X0202 4 2007-01-26 1 0000913275 Solexa, Inc. SLXA 0001207296 HAUSER HERMANN C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD CA 94545 1 0 0 0 Common Stock 2007-01-26 4 D 0 2089849 D 0 I By Amadeus II A LP Common Stock 2007-01-26 4 D 0 1393234 D 0 I By Amadeus II B LP Common Stock 2007-01-26 4 D 0 975264 D 0 I By Amadeus II C LP Common Stock 2007-01-26 4 D 0 46442 D 0 I By Amadeus II D GmbH and Co KG Common Stock 2007-01-26 4 D 0 139322 D 0 I By Amadeus II Affiliates LP Stock Option (Right to Buy) 9.06 2007-01-26 4 D 0 10000 0.00 D 2016-10-03 Common Stock 10000 0 D Stock Option (Right to Buy) 6.20 2007-01-26 4 D 0 20000 0.00 D 2015-10-21 Common Stock 20000 0 D Warrant (Right to Buy) 7.50 2007-01-26 4 D 0 60577 0.00 D 2011-01-19 Common Stock 60577 0 I By Amadeus II LP Warrant (Right to Buy) 7.50 2007-01-26 4 D 0 40385 0.00 D 2011-01-19 Common Stock 40385 0 I By Amadeus II B LP Warrant (Right to Buy) 7.50 2007-01-26 4 D 0 28269 0.00 D 2011-01-19 Common Stock 28269 0 I By Amadeus II C LP Warrant (Right to Buy) 7.5 2007-01-26 4 D 0 1346 0.00 D 2011-01-19 Common Stock 1346 0 I By Amadeus II D GmbH and Co KG Warrant (Right to Buy) 7.5 2007-01-26 4 D 0 4038 0.00 D 2011-01-19 Common Stock 4038 0 I By Amadeus II Affiliates LP These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 718,908 shares of Illumina, Inc. common stock. These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 479,272 shares of Illumina, Inc. common stock. These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 335,490 shares of Illumina, Inc. common stock. These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 15,976 shares of Illumina, Inc. common stock. These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 47,926 shares of Illumina, Inc. common stock. This option, which provided for vesting monthly and ratably over the 12 month period beginning on October 21, 2005, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 6,880 shares at an exercise price of $18.02 per share. This option, which provided for vesting monthly and ratably over the 12 month period beginning on October 4, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 3,440 shares at an exercise price of $26.34 per share. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 20,838 shares at an exercise price of $21.80 per share. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 13,892 shares at an exercise price of $21.80 per share. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 9,724 shares at an exercise price of $21.80 per share. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 463 shares at an exercise price of $21.80 per share. This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 1,389 shares at an exercise price of $21.80 per share. /s/ Hermann Hauser, by Kathy San Roman, attorney-in-fact 2007-01-29 -----END PRIVACY-ENHANCED MESSAGE-----